{"id":140260,"date":"2025-09-13T05:08:33","date_gmt":"2025-09-13T05:08:33","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/140260\/"},"modified":"2025-09-13T05:08:33","modified_gmt":"2025-09-13T05:08:33","slug":"pill-shows-promise-in-lowering-blood-pressure-slowing-kidney-disease","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/140260\/","title":{"rendered":"Pill shows promise in lowering blood pressure, slowing kidney disease"},"content":{"rendered":"<p class=\"mb-4 text-lg md:leading-8 break-words\">A novel pill that blocks the hormone aldosterone shows promise for lowering <a href=\"https:\/\/www.healthday.com\/a-to-z-health\/hypertension\/high-blood-pressure-hypertension-645539.html\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:blood pressure;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">blood pressure<\/a> and potentially delaying the progression of kidney disease in people with both conditions.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The preliminary findings were presented Saturday at an American Heart Association meeting in Baltimore and simultaneously published in the Journal of the American Society of Nephrology.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The Phase 2 clinical trial, known as FigHTN, found that the new medication, baxdrostat, yielded a roughly 5% reduction in systolic blood pressure when given to patients with chronic kidney disease who were unable to control their high blood pressure with existing medications.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Systolic blood pressure is the top number in a blood pressure reading. It measures pressure against your artery walls as the heart beats, according to the AHA.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">&#8220;These findings are encouraging for people living with chronic kidney disease and high blood pressure, two conditions that often go hand-in-hand and create a dangerous cycle,&#8221; said study leader <a href=\"https:\/\/healthcare.utah.edu\/find-a-doctor\/jamie-p-dwyer\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Dr. Jamie Dwyer;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Dr. Jamie Dwyer<\/a>, a professor of medicine at University of Utah Health in Salt Lake City.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Unmanaged blood pressure can worsen kidney function, and declining kidney function can, in turn, further elevate blood pressure, creating a challenging loop for patients, he explained.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Reported previously in HealthDay News, the new <a href=\"https:\/\/www.healthday.com\/health-news\/cardiovascular-diseases\/daily-pill-might-help-people-with-stubborn-high-blood-pressure\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:drug;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">drug<\/a> also showed benefit in other patients with treatment-resistant high blood pressure when taken once a day for three months.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">In an additional analysis, researchers investigated the drug&#8217;s potential impact on kidney function directly.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Participants taking baxdrostat had a 55% reduction in the amount of albumin lost in their urine compared to those on a placebo.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">High levels of albumin in urine are considered a predictor of heart and kidney disease.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">This discovery gives researchers hope for a longer-term benefit, according to Dwyer.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">&#8220;The reduction in urine albumin gives us hope that baxdrostat may also help delay kidney damage,&#8221; he said. He added that this potential is now being further evaluated in two large-scale Phase 3 trials.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The FigHTN study included 195 participants with an average age of 66 who were already on existing blood pressure medication but still had a high average systolic blood pressure of 151 mm Hg.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The participants also had a level of chronic kidney disease, but were not in kidney failure. For 26 weeks, they were given either a low-dose or high-dose of baxdrostat or a placebo in addition to their standard care.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The most common side effect was elevated potassium levels in the blood, which occurred in 41% of those on the drug compared to just 5% in the placebo group, although most cases were mild to moderate, researchers noted.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\"><a href=\"https:\/\/dbei.med.upenn.edu\/staff\/jordana-cohen-md-msce\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Dr. Jordana Cohen;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Dr. Jordana Cohen<\/a> is deputy director and associate professor of medicine and epidemiology at UPenn&#8217;s Perelman School of Medicine and immediate past chair of the AHA&#8217;s Hypertension and Kidney Cardiovascular Science Committee.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">After reviewing the findings, she noted their importance for patients with kidney disease.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">&#8220;It is particularly reassuring to know that patients with chronic kidney disease, who have very high rates of hypertension and elevated renin-angiotensin aldosterone activity, were represented in their own study, tolerated the medication well, and had both blood pressure and albuminuric benefits,&#8221; she said in an AHA news release.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">&#8220;This medication class could be a game changer in the management of hypertension in this patient group,&#8221; Cohen said.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The study was funded by AstraZeneca, developer of baxdrostat.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">More information<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The Mayo Clinic has more about <a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/chronic-kidney-disease\/symptoms-causes\/syc-20354521\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:chronic kidney disease;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">chronic kidney disease<\/a>.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Copyright \u00a9 2025 HealthDay. All rights reserved.<\/p>\n<p><img alt=\"\" loading=\"lazy\" width=\"71\" height=\"22\" decoding=\"async\" data-nimg=\"1\" class=\"rounded-lg\" style=\"color:transparent\" src=\"https:\/\/s.yimg.com\/ny\/api\/res\/1.2\/me4jp9zxq1p8kx0fUBRyNw--\/YXBwaWQ9aGlnaGxhbmRlcjt3PTExMDtoPTM0O2NmPXdlYnA-\/https:\/\/media.zenfs.com\/en\/united_press_international_articles_356\/6cded3008b014d837d16c696f69f43ae\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"A novel pill that blocks the hormone aldosterone shows promise for lowering blood pressure and potentially delaying the&hellip;\n","protected":false},"author":2,"featured_media":140261,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[42960,8431,75476,49,48,50012,84,392,40745,75478,45167,74032,75477],"class_list":["post-140260","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-american-heart-association","tag-blood-pressure","tag-blood-pressure-medication","tag-ca","tag-canada","tag-chronic-kidney-disease","tag-health","tag-healthcare","tag-high-blood-pressure","tag-jamie-dwyer","tag-kidney-disease","tag-kidney-failure","tag-kidney-function"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/140260","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=140260"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/140260\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/140261"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=140260"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=140260"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=140260"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}